JESSICA COCKERHAM: Open Payments
NPI 1063727212 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 14 payments from 7 companies in 2025. Trend: 2023 $1,037 · 2024 $1,311 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $363 |
| Teva Pharmaceuticals USA, Inc. | 3 | $354 |
| ABBVIE INC. | 2 | $245 |
| TMS NeuroHealth Centers Inc. | 1 | $139 |
| Alkermes, Inc. | 1 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $108 |
| Janssen Pharmaceuticals, Inc | 1 | $96 |
Products named: COBENFY, AUSTEDO XR, TMS NeuroHealth Centers Inc., VRAYLAR, LYBALVI, MAVYRET, UZEDY, CAPLYTA.
Industry payments across NC — which companies pay providers there.
